AVAH vs. ESPR
AVAH (Aveanna Healthcare Holdings Inc.) and ESPR (Esperion Therapeutics, Inc.) are both stocks. Both are in the Healthcare sector — AVAH in Medical Care Facilities, ESPR in Biotechnology. Over the past 5 years, AVAH returned -10.99%/yr vs -34.62%/yr for ESPR. At a 0.22 correlation, their price movements are largely independent.
Performance
AVAH vs. ESPR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AVAH achieves a -13.22% return, which is significantly higher than ESPR's -14.86% return.
AVAH
- 1D
- 1.29%
- 1M
- 4.73%
- YTD
- -13.22%
- 6M
- -21.40%
- 1Y
- 39.57%
- 3Y*
- 72.97%
- 5Y*
- -10.99%
- 10Y*
- —
ESPR
- 1D
- 0.00%
- 1M
- 0.96%
- YTD
- -14.86%
- 6M
- -18.18%
- 1Y
- 162.50%
- 3Y*
- 35.36%
- 5Y*
- -34.62%
- 10Y*
- -14.95%
AVAH vs. ESPR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
AVAH Aveanna Healthcare Holdings Inc. | -13.22% | 78.77% | 70.52% | 243.59% | -89.46% | -38.33% |
ESPR Esperion Therapeutics, Inc. | -14.86% | 68.18% | -26.42% | -52.01% | 24.60% | -81.79% |
Correlation
The correlation between AVAH and ESPR is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.19 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Apr 28, 2021 | 0.22 |
Fundamentals
AVAH:
$1.57B
ESPR:
$791.76M
AVAH:
$1.20
ESPR:
-$0.03
AVAH:
0.61
ESPR:
1.75
AVAH:
$2.52B
ESPR:
$418.24M
AVAH:
$823.98M
ESPR:
$226.32M
AVAH:
$306.37M
ESPR:
$77.18M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AVAH vs. ESPR — Risk / Return Rank
AVAH
ESPR
AVAH vs. ESPR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Aveanna Healthcare Holdings Inc. (AVAH) and Esperion Therapeutics, Inc. (ESPR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AVAH | ESPR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.18 | ||
| Sortino ratioReturn per unit of downside risk | -1.23 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 1.36 | -0.16 |
| Calmar ratioReturn relative to maximum drawdown | 1.01 | 3.07 | -2.07 |
| Martin ratioReturn relative to average drawdown | 1.81 | 7.68 | -5.87 |
Loading charts...
Drawdowns
AVAH vs. ESPR - Drawdown Comparison
The maximum AVAH drawdown since its inception was -94.76%, roughly equal to the maximum ESPR drawdown of -99.37%. Use the drawdown chart below to compare losses from any high point for AVAH and ESPR.
Loading charts...
Drawdown Indicators
| AVAH | ESPR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.76% | -99.37% | +4.61% |
Max Drawdown (1Y)Largest decline over 1 year | -39.44% | -53.19% | +13.75% |
Max Drawdown (3Y)Largest decline over 3 years | -41.40% | -80.94% | +39.54% |
Max Drawdown (5Y)Largest decline over 5 years | -94.76% | -97.16% | +2.40% |
Max Drawdown (10Y)Largest decline over 10 years | — | -99.10% | — |
Current DrawdownCurrent decline from peak | -45.00% | -97.27% | +52.27% |
Average DrawdownAverage peak-to-trough decline | -63.57% | -69.99% | +6.42% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 21.95% | 21.30% | +0.65% |
Volatility
AVAH vs. ESPR - Volatility Comparison
Aveanna Healthcare Holdings Inc. (AVAH) has a higher volatility of 15.70% compared to Esperion Therapeutics, Inc. (ESPR) at 1.06%. This indicates that AVAH's price experiences larger fluctuations and is considered to be riskier than ESPR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AVAH | ESPR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.70% | 1.06% | +14.64% |
Volatility (6M)Calculated over the trailing 6-month period | 32.16% | 61.44% | -29.28% |
Volatility (1Y)Calculated over the trailing 1-year period | 68.16% | 92.66% | -24.50% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 78.16% | 91.79% | -13.63% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 77.42% | 84.61% | -7.19% |
Dividends
AVAH vs. ESPR - Dividend Comparison
Neither AVAH nor ESPR has paid dividends to shareholders.
Financials
AVAH vs. ESPR - Financials Comparison
This section allows you to compare key financial metrics between Aveanna Healthcare Holdings Inc. and Esperion Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AVAH vs. ESPR - Profitability Comparison
AVAH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Aveanna Healthcare Holdings Inc. reported a gross profit of 202.38M and revenue of 647.92M. Therefore, the gross margin over that period was 31.2%.
ESPR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Esperion Therapeutics, Inc. reported a gross profit of 0.00 and revenue of 80.10M. Therefore, the gross margin over that period was 0.0%.
AVAH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Aveanna Healthcare Holdings Inc. reported an operating income of 75.94M and revenue of 647.92M, resulting in an operating margin of 11.7%.
ESPR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Esperion Therapeutics, Inc. reported an operating income of -6.58M and revenue of 80.10M, resulting in an operating margin of -8.2%.
AVAH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Aveanna Healthcare Holdings Inc. reported a net income of 41.65M and revenue of 647.92M, resulting in a net margin of 6.4%.
ESPR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Esperion Therapeutics, Inc. reported a net income of -25.20M and revenue of 80.10M, resulting in a net margin of -31.5%.
Frequently Asked Questions
AVAH and ESPR have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AVAH has higher volatility (15.70%) compared to ESPR (1.06%). In terms of maximum drawdown, AVAH dropped -94.76% vs ESPR's -99.37%.
ESPR currently has the higher Sharpe Ratio (1.76 vs 0.58), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AVAH and ESPR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer